About Us


Principals:

Ivan Lavernia, M.D. - Director

Dr. Lavernia has been on the South Florida health care scene since the 1970’s, as Primary Care physician, managed care provider and North Broward Hospital District Commissioner.

Dr. Lavernia was a founding principal of Heritage Health Plan of Florida, which was later merged into CareFlorida and sold for more than $230 million.

Richard J. Lucibella, MHS, MBA - CEO and Director

Mr. Lucibella earned a Master in Health Science from Johns Hopkins and Master in Business Administration from the Wharton School.

He began his career with the Health Care Financing Administration (Medicare) and was directly involved in the original Medicare HMO risk projects.

Mr. Lucibella has been active in South Florida Medicare risk programs since the mid 1980’s.

Francisco Perez-Mesa, M.D. - Director

Dr. Perez-Mesa has been a practicing Primary Care physician in South Florida since the early 1990’s.

His entire career has been focused on Medicare risk contracting and Medicare Advantage programs.

Today, Dr. Perez is responsible for managing the care and health of more than 6,000 Medicare Advantage patients in Broward and Palm Beach counties.

Organizational Information:

ACO Name and Location

Accountable Care Options, LLC 

2240 W. Woolbright Road

Suite 317

Boynton Beach, FL 33426

Accountable Care Options Primary Contact

Richard J. Lucibella

561-200-0325

Rich@aco-fl.com

Hours of Operation: 9 a.m – 5 p.m., Monday–Friday

Composition of Accountable Care Options:

N/A

Organizational Information

Accountable Care Options Participants
ACO participants in joint ventures between ACO professionals and hospitals
  • No participants are involved in a joint venture between ACO professionals and hospitals.
Accountable Care Options Governing Body
  • Richard J. Lucibella, MHS, MBA, Voting Member and CEO, Accountable Care Options, LLC
  • Francisco Perez-Mesa, M.D., Voting Member and ACO Participant, UniMed HealthCare, LLC
  • Jack Halickman, M.D., Voting Member and ACO Participant, Family Practice & Internal Medicine of The Palm Beaches, LLC
  • David Mishkin, D.O., Voting Member and ACO Participant, David Mishkin, D.O., P.A.
  • Mitchell Perelman, M.D., Voting Member and ACO Participant, Cambridge Medical Group of West Boynton, LLC
  • David Rodriguez, Voting Member and ACO Participant , Amicus Medical Center LLC
  • Louis Tumminia, D.O., Voting Member and ACO Participant, Tumminia Internal Medicine, P.A.
  • Ivan Lavernia, M.D., Voting Member and ACO Participant, Boynton Physicians Group, LLC
  • Stephen Shannon, Voting Member, Medicare Beneficiary Representative
Key ACO Clinical and Administrative Leadership
  • ACO Executive: Richard J. Lucibella, MHS, MBA
  • Medical Director: Zakir H. Khan, M.D., P.A.
  • Compliance Officer: Ramon Voils
  • Quality Assurance/Improvement Officer: Francisco Perez-Mesa, M.D.
Associated Committees and Committee Leadership
  • Chronic Care Management Committee: Zakir Khan, M.D., Chair
Types of ACO Participants or Combinations of Participants that formed the ACO
  • Network of individual practices of ACO professionals

Next Generation ACO Model Overview

The Next Generation ACO Model is an initiative for ACOs that are experienced in coordinating care for populations of patients.  It will allow these providers groups to assume higher levels of financial risk and reward than are available under the current Pioneer Model and Shared Savings Program.  The goal of the Model is to test whether strong financial incentives for ACOs, coupled with tools to support better patient engagement and care management, can improve health outcomes and lower expenditures for Original Medicare fee-for-service (FFS) beneficiaries.

Included in the Next Generation ACO Model are strong patient protections to ensure that patients have access to and receive high-quality care.  Like other Medicare ACO initiatives, this Model will be evaluated on its ability to deliver better care for individuals, better health for populations, and lower growth in expenditures.  This is in accordance with the Department of Health and Humana Services’ “Better, Smarter, Healthier” approach to improving our nation’s health care and setting clear, measurable goals and a timeline to move the Medicare program – and the health care system at large—toward paying providers based on the quality rather than the quantity of care they provide to patients.  In addition, CMS will publicly report the performance of the Next Generation ACOs on quality metrics, including patient experience ratings, on its website.

For more information, contact the Medicare Service Center at 800-633-4227

Shared Savings and Losses - Medicare Shared Savings Program: Amount of Shared Savings/Losses

  • Agreement period beginning 2013, Performance Year 1: $6.25 million
  • Agreement period beginning 2013, Performance Year 2014: $4.42 million
  • Agreement period beginning 2013, Performance Year 2015: $7.4 million

Shared Savings Distribution - Medicare Shared Savings Program

  • Agreement period beginning 2013, Performance Year 1

    • Proportion invested in infrastructure: 30%
    • Proportion invested in redesigned processes: 0%
    • Proportion of distribution to ACO participants: 70%
  • Agreement period beginning 2013, Performance Year 2014, 2015

    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned processes: 10%
    • Proportion of distribution to ACO participants: 70%

Payment Rule Waivers

Yes, our ACO utilizes the SNF 3-Day Rule Waiver.

  1. St. Anthony’s Rehabilitation Hospital
  2. St. John’s Nursing Center
  3. Lakeside Health Center (Life Care Centers of America)
  4. The Gardens Court (Life Care Centers of America)
  5. Willowbrooke Court at St. Andrews Estates
  6. Willowbrooke Court at Edgewater Pointe Estates
  7. Abbey Delray South
  8. Sunrise Senior Living Services
  9. Joseph L. Morse Health Center, Inc.
  10. Darcy Hall of Life Care (Life Care Centers of America)

Quality Measure Results

Jump to results for 2012-2014

Jump to results for 2015

Jump to results for 2017

Quality Performance Results Table, 2012-2014 - Medicare Shared Savings Program

Measure Number

Performance measure

2012 reporting period

2013 reporting period

2014 reporting period

ACO performance rate

Mean performance rate for all ACOs

ACO performance rate

Mean performance rate for all ACOs

ACO performance rate

Mean performance rate for all ACOs

ACO #1 Getting Timely Care, Appointments, and Information 81.32 80.13
ACO #2 How Well Your Doctors Communicate 92.12 92.39
ACO #3 Patients' Rating of Doctor 90.77 91.58
ACO #4 Access to Specialists 86.17 83.97
ACO #5 Health Promotion and Education 59.20 58.29
ACO #6 Shared Decision Making 77.26 74.60
ACO #7 Health Status/Functional Status 70.19 71.10
ACO #8 Risk Standardized, All Condition Readmissions 15.27 15.42 15.12 14.90 15.36 15.15
ACO #9 ASC Admissions: COPD or Asthma in Older Adults 1.12 1.13 1.12 1.17 1.39 1.08
ACO #10 ASC Admission: Heart Failure 1.00 1.09 1.29 1.20 1.08 1.19
ACO #11 Percent of PCPs who Qualified for EHR Incentive Payment 16.67 25.70 33.33 66.21 61.54 76.71
ACO #12 Medication Reconciliation 91.63 82.61
ACO #13 Falls: Screening for Fall Risk 78.24 45.60
ACO #14 Influenza Immunization 61.64 57.51
ACO #15 Pneumococcal Vaccination 60.96 55.03
ACO #16 Adult Weight Screening and Follow-up 92.98 66.75
ACO #17 Tobacco Use Assessment and Cessation Intervention 96.37 86.79
ACO #18 Depression Screening 73.29 39.27
ACO #19 Colorectal Cancer Screening 54.99 56.14
ACO #20 Mammography Screening 71.09 61.41
ACO #21 Proportion of Adults who had blood pressure screened in past 2 years 95.25 60.24
ACO #22 Hemoglobin A1c Control (HbA1c) (<8 percent) 79.74 N/A
ACO #23 Low Density Lipoprotein (LDL) (<100 mg/dL) N/A N/A
ACO #24 Blood Pressure (BP) <140/90 78.70 N/A
ACO #25 Tobacco Non Use 83.64 N/A
ACO #26 Aspirin Use 91.43 N/A
ACO #27 Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) 10.27 20.35
ACO #28 Percent of beneficiaries with hypertension whose BP <140/90 76.01 68.02
ACO #29 Percent of beneficiaries with IVD with complete lipid profile and LDL control <100mg/dL N/A N/A
ACO #30 Percent of beneficiaries with IVD who use Aspirin or other antithrombotic 88.96 80.79
ACO #31 Beta-Blocker Therapy for LVSD 78.38 82.71
ACO #32 Drug Therapy for Lowering LDL Cholesterol N/A N/A
ACO #33 ACE Inhibitor or ARB Therapy for Patients with CAD and Diabetes and/or LVSD 80.98 N/A

Quality Performance Results Table, 2015 - Medicare Shared Savings Program

Measure Number

Measure Name

2015 reporting period

ACO performance rate

Mean performance rate (SSP- ACOs)

ACO #1 CAHPS: Getting Timely Care, Appointments, and Information 79.03 80.61
ACO #2 CAHPS: How Well Your Providers Communicate 93.09 92.65
ACO #3 CAHPS: Patients' Rating of Provider 91.29 91.94
ACO #4 CAHPS: Access to Specialists 83.94 83.61
ACO #5 CAHPS: Health Promotion and Education 61.38 59.06
ACO #6 CAHPS: Shared Decision Making 76.18 75.17
ACO #7 CAHPS: Health Status/Functional Status 73.87 72.30
ACO #8 Risk Standardized, All Condition Readmissions 14.96 14.86
ACO #9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 1.27 1.11
ACO #10 Ambulatory Sensitive Conditions Admission: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 1.00 1.04
ACO #11 Percent of Primary Care Physicians who Successfully Meet Meaningful Use Requirements 65.38 76.22
ACO #12 Medication Reconciliation
ACO #13 Falls: Screening for Future Fall Risk 82.80 56.46
ACO #14 Preventive Care and Screening: Influenza Immunization 75.39 62.03
ACO #15 Pneumonia Vaccination Status for Older Adults 66.89 63.73
ACO #16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up 87.86 71.15
ACO #17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 97.49 90.16
ACO #18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up 72.55 45.25
ACO #19 Colorectal Cancer Screening 63.59 60.06
ACO #20 Breast Cancer Screening 68.92 65.67
ACO #21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 82.82 70.04
ACO #22 Hemoglobin A1c Control (HbA1c) (<8 percent)
ACO #23 Low Density Lipoprotein (LDL) (<100 mg/dL)
ACO #24 Blood Pressure (BP) <140/90
ACO #25 Tobacco Non Use
ACO #26 Aspirin Use
ACO #27 Diabetes Mellitus: Hemoglobin A1c Poor Control 10.53 20.38
ACO #28 Hypertension: Controlling High Blood Pressure 74.29 69.62
ACO #29 Percent of beneficiaries with IVD with complete lipid profile and LDL control <100mg/dL
ACO #30 Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic 88.58 83.82
ACO #31 Heat Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 83.12 87.22
ACO #32 Drug Therapy for Lowering LDL Cholesterol
ACO #33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for Patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 74.23 77.73
ACO #34 CAHPS: Stewardship of Patient Resources 26.32 26.87
ACO #35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM) 17.79 18.07
ACO #36 All-Cause Unplanned Admissions for Patients with Diabetes 49.42 54.60
ACO #37 All-Cause Unplanned Admissions for Patients with Heart Failure 67.06 76.96
ACO #38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 53.40 62.92
ACO #39 Documentation of Current Medications in the Medical Record 97.51 84.07
ACO #40 Depression Remission at Twelve Months N/A N/A
ACO #41 Diabetes: Eye Exam 29.89 41.05

Shared Savings and Losses - Medicare Next Generation ACO Program: Amount of Shared Savings/Losses

  • Agreement period beginning 2017, Performance Year 2: $8.74 million

  • Proportion invested in infrastructure: 44.5%

  • Proportion of distribution to ACO, Participants and Preferred Providers: 55.5%

Measure Number

Quality Performance Results Table

Measure Name

2017 reporting period
ACO performance rate Mean performance rate (NGACOs)
ACO #1 CAHPS: Getting Timely Care, Appointments, and Information 84.95 81.29
ACO #2 CAHPS: How Well Your Providers Communicate 93.69 93.20
ACO #3 CAHPS: Patients' Rating of Provider 91.98 92.41
ACO #4 CAHPS: Access to Specialists 83.81 82.83
ACO #5 CAHPS: Health Promotion and Education 65.28 62.51
ACO #6 CAHPS: Shared Decision Making 73.69 74.98
ACO #7 CAHPS: Health Status/Functional Status 72.54 73.37
ACO #8^ Risk Standardized, All Condition Readmissions 15.39 15.18
ACO #12 Medication Reconciliation Post-Discharge 93.15% 63.87%
ACO #13 Falls: Screening for Future Fall Risk 94.39% 74.09%
ACO #14 Preventive Care and Screening: Influenza Immunization 85.96% 74.14%
ACO #15 Pneumonia Vaccination Status for Older Adults 76.68% 76.65%
ACO #16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up 91.44% 64.16%
ACO #17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 97.87% 90.16%
ACO #18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 86.42% 59.12%
ACO #19 Colorectal Cancer Screening 77.43% 69.70%
ACO #20 Breast Cancer Screening 79.06% 72.55%
Diabetes Composite Diabetes Composite (all or nothing scoring) 54.27% 44.91%
ACO #27^ Diabetes Mellitus: Hemoglobin A1c Poor Control 9.30% 16.60%
ACO #28 Hypertension (HTN) : Controlling High Blood Pressure 86.24% 74.19%
ACO #30 Ischemic Vascular Disease (IVD) : Use of Aspirin or Another Antithrombotic 93.97% 86.80%
ACO #34 CAHPS: Stewardship of Patient Resources 25.51 24.54
ACO #35^ Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM) 18.40 18.66
ACO #37^ All-Cause Unplanned Admissions for Patients with Heart Failure 63.51 80.35
ACO #38^ All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 51.41 62.08
ACO #40 Depression Remission at Twelve Months 13.16% 6.11%
ACO #41 Diabetes: Eye Exam 57.50% 51.17%
ACO#42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 86.17% 80.94%
ACO#43^ Ambulatory Sensitive Condition Acute Composite (AHRQ Prevention Quality Indicator (PQI) #91) 1.51 1.73
ACO#44 Use of Imaging Studies for Low Back Pain 33.33% 68.01%

2240 Woolbright Road • Suite 317 • Boynton Beach, FL 33426 • 561-200-0325 • aco-fl.com
This site is best viewed with HTML5 compliant browsers